Eikon Therapeutics Tech Stack

Eikon Therapeutics uses 8 technology products and services including AutoCad, jsDelivr, Exhibit, and more. Explore Eikon Therapeutics's tech stack below.

  • AutoCad
    Cad & Graphics
  • jsDelivr
    Content Delivery Network
  • Exhibit
    Javascript Graphics
  • Splunk
    Miscellaneous
  • Microsoft
    Miscellaneous
  • C#
    Programming Languages
  • Jobvite
    Recruitment Marketing
  • Flask
    Web Frameworks

Media & News

Eikon Therapeutics's Email Address Formats

Eikon Therapeutics uses at least 4 format(s):
Eikon Therapeutics Email FormatsExamplePercentage
lf@eikontx.comDJ@eikontx.com
25%
first.last@eikontx.comJohn.Doe@eikontx.com
25%
lastf@eikontx.comDoeJ@eikontx.com
25%
f.last@eikontx.comJ.Doe@eikontx.com
25%

Frequently Asked Questions

Where is Eikon Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Eikon Therapeutics's main headquarters is located at 3929 Point Eden Way Hayward, CA 94545 US. The company has employees across 5 continents, including North AmericaEuropeSouth America.

What is Eikon Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Eikon Therapeutics's official website is eikontx.com and has social profiles on LinkedIn.

How much revenue does Eikon Therapeutics generate?

Minus sign iconPlus sign icon
As of March 2024, Eikon Therapeutics's annual revenue reached $35M.

What is Eikon Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Eikon Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Eikon Therapeutics have currently?

Minus sign iconPlus sign icon
As of March 2024, Eikon Therapeutics has approximately 349 employees across 5 continents, including North AmericaEuropeSouth America. Key team members include Chief People Officer: B. H. S.Chief Financial Officer: A. F. B.Chief Business Officer & General Counsel: B. T.. Explore Eikon Therapeutics's employee directory with LeadIQ.

What industry does Eikon Therapeutics belong to?

Minus sign iconPlus sign icon
Eikon Therapeutics operates in the Biotechnology Research industry.

What technology does Eikon Therapeutics use?

Minus sign iconPlus sign icon
Eikon Therapeutics's tech stack includes AutoCadjsDelivrExhibitSplunkMicrosoftC#JobviteFlask.

What is Eikon Therapeutics's email format?

Minus sign iconPlus sign icon
Eikon Therapeutics's email format typically follows the pattern of lf@eikontx.com. Find more Eikon Therapeutics email formats with LeadIQ.

How much funding has Eikon Therapeutics raised to date?

Minus sign iconPlus sign icon
As of March 2024, Eikon Therapeutics has raised $106M in funding. The last funding round occurred on Jun 01, 2023.

When was Eikon Therapeutics founded?

Minus sign iconPlus sign icon
Eikon Therapeutics was founded in 2019.
Eikon Therapeutics

Eikon Therapeutics

Biotechnology ResearchCalifornia, United States201-500 Employees

Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the interface of biology, engineering and chemistry to discover novel treatments for life-threatening diseases. Eikon’s discovery platform is built on groundbreaking innovations from its founders (Nobel Prize, 2014), culminating in the creation of microscopes which enable real time, molecular-resolution measurements of protein movement in living cells. 

By directly measuring the effects of chemical compounds on the behavior of protein molecules in a live cellular environment, Eikon’s landmark assays facilitate the highly sensitive identification of compound-protein interactions that could not be identified through traditional assays, thereby unlocking otherwise intractable classes of proteins as drug targets. Furthermore, the ability to directly visualize protein mechanisms in disease coupled with the extraordinarily high-powered high-content data sets generated by Eikon’s drug-screening technology enable an unprecedented opportunity to quantitatively explore novel biology in the living cell. These insights facilitate creation and application of data-driven hypotheses to the discovery of life-saving therapies. 

Eikon is seeking adventurous, passionate and creative team members eager to apply their talents to empower interdisciplinary scientific exploration, inaugurate a radical drug-discovery paradigm, and ultimately create novel medicines. To learn more about open positions, please visit:  https://eikontx.com/team#positions

Section iconCompany Overview

Headquarters
3929 Point Eden Way Hayward, CA 94545 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
201-500

Section iconFunding & Financials

  • $106M

    Eikon Therapeutics has raised a total of $106M of funding over 4 rounds. Their latest funding round was raised on Jun 01, 2023.

  • $10M$50M

    Eikon Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $106M

    Eikon Therapeutics has raised a total of $106M of funding over 4 rounds. Their latest funding round was raised on Jun 01, 2023.

  • $10M$50M

    Eikon Therapeutics's revenue is in the range of $10M$50M

© LeadIQ, Inc. All rights reserved.